Abrocitinib Sustains Skin Clearance in Moderate and Severe Atopic Dermatitis Through 112 Weeks
A post-hoc analysis of the JADE COMPARE and JADE EXTEND trials found that abrocitinib produced early and sustained skin clearance ...
Tag: abrocitinib
POPULAR NEWS
-
ARISE trial to test diabetes distress screening and care workflows in community health centers
-
Necroptosis emerges as a decisive switch between tumor immunity and cancer growth
-
Taiwan-Chinese Version of Palliative Care Outcome Tools Developed Through Expert Adaptation
-
From Association to Cause: Review Maps Causal Inference Methods for Alzheimer’s Molecular Data